
    
      Interbody fusion in patients with degenerative disc disease (DDD) at one or two contiguous
      levels from L2 to S1. Patients may also have up to Grade I spondylolisthesis or
      retrolisthesis at the involved level(s). Patients should be skeletally mature and have
      completed six months of non-operative treatment
    
  